• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Twist Ties & Tape: MITA Highlights the Need for Third-Party Servicer FDA Registration

Video

The alliance is calling for all third-party medical equipment servicers to be required to register with – and abide by regulations from – the FDA.

Worries over equipment maintenance provided by third-party servicers has been a long-standing concern for radiology leaders. In its latest push for greater safety, the Medical Imaging & Technology Alliance (MITA) released a white paper this week, calling for third-party servicers to register with the U.S. Food & Drug Administration (FDA).

Related Content: MITA Calls for FDA Registration for Third-Party Medical Device Servicers

Currently, third-party groups are not subject to the same requirements and regulations that govern original equipment manufacturers and healthcare facilities. Instead, they abide by voluntary standards. This situation has resulted in multiple scenarios that put both patients and providers at significant risk, including instances of equipment that have been repaired with tape or twist ties, as well as improper ventilation.

Related Content: Hey FDA, There’s No Need to Add to Cancer Patients' Scanxiety

Diagnostic Imaging spoke this week with Peter Weems, MITA senior director of strategic operations and policy, about the pervasiveness of this issue and the threats it presents. He also shared details on the ongoing efforts to require FDA registration for these services and what individual radiologists and rad techs can do to participate, directing providers and other interested parties to Protect Safe Servicing, a website that can provide more information about the risks of third-party servicing, how to address the problem, and case studies of unsafe incidents.

Recent Videos
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Related Content
© 2025 MJH Life Sciences

All rights reserved.